title: Senicapoc trial results support the existence of different sub-phenotypes of sickle cell disease with possible drug-induced phenotypic shifts.
authors: Oswaldo L
authors: OL
authors: Castro
authors: Victor R
authors: VR
authors: Gordeuk
authors: Mark T
authors: MT
authors: Gladwin
authors: Martin H
authors: MH
authors: Steinberg
mesh_terms: D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use*; D000755:Anemia, Sickle Cell / Q000097:blood / Q000145:classification* / Q000188:drug therapy*; D006451:Hemoglobin, Sickle / Q000378:metabolism; D006801:Humans; D010146:Pain / Q000139:chemically induced; D010641:Phenotype; D016032:Randomized Controlled Trials as Topic; D014320:Triphenylmethyl Compounds / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D006451:Hemoglobin, Sickle; D014320:Triphenylmethyl Compounds; C472774:senicapoc